Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award : Priority Announcement - HIV/AIDS

Université de Montréal

$105,000.00

Role of HIV-1 envelope glycoproteins variable regions in ADCC responses

FY 2017-18

Summary
Around the world, it is estimated that about 37 million people live with the human immunodeficiency virus (HIV). In Canada alone, between 63,000 to 89,000 individuals live with HIV/AIDS and there are thousands of new infections each year. In the absence of an efficient vaccine against HIV and treatments still far away from eradicating the virus, we need to find new approaches to fight this virus. Recent studies have shown that our immune system already possess potentially effective protective mechanism against HIV infection, the antibody-dependant cell-mediated cytotoxicity (ADCC) response. However, to be efficient, our immune system has to recognize HIV-infected cells first. We are currently studying a mechanism that enables optimal recognition of infected cells by the immune system. The findings of this study will help us to progress in finding a functional cure for HIV-infected patients by sensitizing specifically HIV-infected cells to a strong ADCC response. Moreover, some of these results might be useful at designing new immunogens able to elicit a protective response and thus decrease HIV-1 transmission.
Program
Doctoral Research Award : Priority Announcement - HIV/AIDS
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
378370
Name
Prévost Jérémie
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of HIV-1 envelope glycoproteins variable regions in ADCC responses
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award : Priority Announcement - HIV/AIDS
Keyworddelim
Adcc; Antibody; Env; Facs; Gp120; Hiv-1; Molecular Biology; Virology
Abstract
Around the world, it is estimated that about 37 million people live with the human immunodeficiency virus (HIV). In Canada alone, between 63,000 to 89,000 individuals live with HIV/AIDS and there are thousands of new infections each year. In the absence of an efficient vaccine against HIV and treatments still far away from eradicating the virus, we need to find new approaches to fight this virus. Recent studies have shown that our immune system already possess potentially effective protective mechanism against HIV infection, the antibody-dependant cell-mediated cytotoxicity (ADCC) response. However, to be efficient, our immune system has to recognize HIV-infected cells first. We are currently studying a mechanism that enables optimal recognition of infected cells by the immune system. The findings of this study will help us to progress in finding a functional cure for HIV-infected patients by sensitizing specifically HIV-infected cells to a strong ADCC response. Moreover, some of these results might be useful at designing new immunogens able to elicit a protective response and thus decrease HIV-1 transmission.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Prévost, Jérémie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Université de Montréal - $105,000 Grant (2017-18) | Canada Spends